Mebane, North Carolina Clinical Trials

A listing of Mebane, North Carolina clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 350 clinical trials
featured
INCB001158 Combined With Subcutaneous (SC) Daratumumab, Compared to Daratumumab SC, in Relapsed or Refractory Multiple Myeloma

The purpose of this study is to evaluate the safety and antitumor activity of INCB001158 in combination with daratumumab SC, compared with daratumumab SC alone, in participants with relapsed or refractory multiple myeloma who have received at least 3 but not more than 5 prior lines of multiple myeloma therapy. …

refractory multiple myeloma
daratumumab
LINEBERGER COMPREHENSIVE CANCER CENTER AT UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
 (9.7 away) Contact site
  • 73 views
  • 28 May, 2020
  • +27 other locations
featured
The RADIANCE II Pivotal Study: A Study of the ReCor Medical Paradise System in Stage II Hypertension

RADIANCE-II is a pivotal trial, currently enrolling patients, to study the safety and effectiveness of the Paradise System to reduce blood pressure in patients with hypertension, in the absence of antihypertensive medications. RADIANCE-II is currently enrolling patients with uncontrolled blood pressure on 0-2 medications.  

The University of North Carolina at Chapel Hill
 (9.7 away) Contact site
  • 315 views
  • 30 Mar, 2021
  • +20 other locations
featured
Rituximab plus Belimumab for Lupus Nephritis (CALIBRATE Study)

Rituximab plus Belimumab for Lupus Nephritis (CALIBRATE Study)

University of North Carolina
 (9.7 away) Contact site
  • 926 views
  • 25 Mar, 2021
  • +11 other locations
featured
A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma (516-003)

This is a study involving an investigational (experimental) drug called sitravatinib, given in combination with the immunotherapy nivolumab (also known as OPDIVO®).  Sitravatinib is designed to block specific proteins that are thought to cause tumors to grow and to prevent growth of new blood vessels that help cancer tumors to …

platinum-based chemotherapy
advanced urothelial cancer
metastatic urothelial carcinoma
carcinoma
advanced urothelial carcinoma
University of North Carolina - Lineberger Comprehensive Cancer Center
 (9.7 away) Contact site
  • 80 views
  • 02 Jun, 2021
  • +35 other locations
A Randomized Trial to Evaluate Sequential vs Simultaneous Patching

A randomized trial to determine whether simultaneous treatment with spectacles and patching has an equivalent VA outcome compared with sequential treatment, first with spectacles alone followed by patching (if needed), for previously untreated amblyopia in children 3 to <13 years of age.

University of North Carolina
 (9.7 away) Contact site
  • 0 views
  • 18 Jun, 2021
  • +51 other locations
A Study to Assess the Safety and Efficacy of Oral Etrasimod in Adult Participants With Eosinophilic Esophagitis

The purpose of this study is to determine whether oral etrasimod is a safe and effective treatment for active eosinophilic esophagitis (EoE) in adult participants.

University of North Carolina at Chapel Hill
 (9.7 away) Contact site
  • 0 views
  • 20 Jul, 2021
  • +49 other locations
Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis

Phase 2 Study Investigating the Efficacy of AMT-101 in Subjects with Chronic Antibiotic-resistant Pouchitis

University of North Carolina GI
 (9.7 away) Contact site
  • 0 views
  • 10 Jul, 2021
  • +28 other locations
A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis

Study CC-93538-EE-001 is a Phase 3, multicenter, multinational, randomized, double-blind, placebo-controlled induction and maintenance study to evaluate the efficacy and safety of CC- 93538 in adult and adolescent participants with eosinophilic esophagitis (EoE). The study will incorporate a 24-week Induction Phase followed by a 24-week Maintenance Phase. Participants will be …

University of North Carolina at Chapel Hill
 (9.7 away) Contact site
  • 0 views
  • 02 May, 2021
  • +200 other locations
COVID-19 Thrombosis Prevention Trials: Post-hospital Thromboprophylaxis

A multicenter, adaptive, randomized platform trial evaluating the efficacy and safety of antithrombotic strategies in patients with COVID-19 following hospital discharge

University of North Carolina at Chapel Hill
 (9.7 away) Contact site
  • 0 views
  • 04 Aug, 2021
  • +74 other locations
Digital Tomosynthesis Mammography and Digital Mammography in Screening Patients for Breast Cancer

This randomized phase III trial studies digital tomosynthesis mammography and digital mammography in screening patients for breast cancer. Screening for breast cancer with tomosynthesis mammography may be superior to digital mammography for breast cancer screening and may help reduce the need for additional imaging or treatment.

UNC Lineberger Comprehensive Cancer Center
 (9.7 away) Contact site
  • 2012 views
  • 01 Aug, 2021
  • +71 other locations